Jun Guo
Impact in
- Oncology top 1%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Oncology 112
- Cutaneous Melanoma Detection and Management 57
- Cancer Immunotherapy and Biomarkers 47
- CAR-T cell therapy research 36
-
- Melanoma and MAPK Pathways 42
- Co-authors
- Lu Si (134 shared papers)Chuanliang Cui (100 shared papers)Xinan Sheng (107 shared papers)Zhihong Chi (100 shared papers)Lili Mao (59 shared papers)Yan Kong (67 shared papers)Bin Lian (78 shared papers)Jie Dai (55 shared papers)
- Journals
- Journal of Clinical Oncology (70 papers)Annals of Oncology (14 papers)Clinical Cancer Research (7 papers)European Journal of Cancer (6 papers)BMC Cancer (6 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Jun Guo
195 papers receiving 3.5k citations
Jun Guo's Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 1.9k
- Immunology 574
- Cancer Research 379
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 520
Countries citing papers authored by Jun Guo
This map shows the geographic impact of Jun Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Guo more than expected).
Fields of papers citing papers by Jun Guo
This network shows the impact of papers produced by Jun Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Guo. The network helps show where Jun Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 210 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 273 | |
| 2 | Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Hit paper breakdown → | 2020 | 212 |
| 3 | 2011 | 182 | |
| 4 | 2018 | 142 | |
| 5 | 2013 | 122 | |
| 6 | 2021 | 100 | |
| 7 | 2019 | 99 | |
| 8 | 2016 | 99 | |
| 9 | 2013 | 84 | |
| 10 | 2007 | 80 | |
| 11 | 2017 | 74 | |
| 12 | 2021 | 66 | |
| 13 | 2015 | 58 | |
| 14 | 2012 | 57 | |
| 15 | 2016 | 49 | |
| 16 | 2015 | 47 | |
| 17 | 2019 | 44 | |
| 18 | 2019 | 43 | |
| 19 | 2014 | 39 | |
| 20 | 2013 | 38 |
About Jun Guo
Jun Guo is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 210 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (57 papers), Cancer Immunotherapy and Biomarkers (47 papers), Melanoma and MAPK Pathways (42 papers), CAR-T cell therapy research (36 papers), Renal cell carcinoma treatment (35 papers), Immunotherapy and Immune Responses (16 papers), Bladder and Urothelial Cancer Treatments (14 papers) and Cancer Genomics and Diagnostics (12 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (574 citations), Cancer Research (379 citations), Molecular Biology (1.3k citations) and Pulmonary and Respiratory Medicine (520 citations). Jun Guo has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Lu Si, Chuanliang Cui, Xinan Sheng, Zhihong Chi, Lili Mao, Yan Kong, Bin Lian, Jie Dai, Bixia Tang and Xieqiao Yan. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, European Journal of Cancer and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.